G protein-coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects

被引:2
|
作者
Littlepage-Saunders, Mydirah [1 ,2 ]
Hochstein, Michael J. [1 ,3 ]
Chang, Doris S. [1 ,3 ]
Johnson, Kari A. [1 ,2 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Neurosci Grad Program, Bethesda, MD USA
[3] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
cannabinoid receptor; dopamine; G protein-coupled receptor; metabotropic glutamate receptor; muscarinic acetylcholine receptor; opioid receptor; psychoactive drugs; POSITIVE ALLOSTERIC MODULATOR; VENTRAL TEGMENTAL AREA; MUSCARINIC ACETYLCHOLINE-RECEPTORS; METABOTROPIC GLUTAMATE RECEPTORS; NUCLEUS-ACCUMBENS SHELL; INDUCED COCAINE-SEEKING; KAPPA-OPIOID RECEPTOR; LONG-TERM DEPRESSION; IN-VIVO; CHOLINERGIC INTERNEURONS;
D O I
10.1111/bph.16151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dopamine transmission in the striatum is a critical mediator of the rewarding and reinforcing effects of commonly misused psychoactive drugs. G protein-coupled receptors (GPCRs) that bind a variety of neuromodulators including dopamine, endocannabinoids, acetylcholine and endogenous opioid peptides regulate dopamine release by acting on several components of dopaminergic circuitry. Striatal dopamine release can be driven by both somatic action potential firing and local mechanisms that depend on acetylcholine released from striatal cholinergic interneurons. GPCRs that primarily regulate somatic firing of dopamine neurons via direct effects or modulation of synaptic inputs are likely to affect distinct aspects of behaviour and psychoactive drug actions compared with those GPCRs that primarily regulate local acetylcholine-dependent dopamine release in striatal regions. This review will highlight mechanisms by which GPCRs modulate dopaminergic transmission and the relevance of these findings to psychoactive drug effects on physiology and behaviour.
引用
收藏
页码:4399 / 4413
页数:15
相关论文
共 50 条
  • [21] On the G Protein-Coupled Receptor Neuromodulation of the Claustrum
    Borroto-Escuela, Dasiel O.
    Fuxe, Kjell
    NEUROCHEMICAL RESEARCH, 2020, 45 (01) : 5 - 15
  • [22] What are the current trends in G protein-coupled receptor targeted drug discovery?
    Casado, Vicent
    Casado-Anguera, Veronica
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (08) : 815 - 820
  • [23] Complexing receptor pharmacology - Modulation of family B G protein-coupled receptor function by RAMPs
    Sexton, Patrick M.
    Morfis, Maria
    Tilakaratne, Nanda
    Hay, Debbie L.
    Udawela, Madhara
    Christopoulos, George
    Christopoulos, Arthur
    VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY, 2006, 1070 : 90 - 104
  • [24] Arrestin recruitment and signaling by G protein-coupled receptor heteromers
    Mores, Kendall L.
    Cassell, Robert J.
    van Rijn, Richard M.
    NEUROPHARMACOLOGY, 2019, 152 : 15 - 21
  • [25] On the G Protein-Coupled Receptor Neuromodulation of the Claustrum
    Dasiel O. Borroto-Escuela
    Kjell Fuxe
    Neurochemical Research, 2020, 45 : 5 - 15
  • [26] G protein-coupled receptor (GPCR) pharmacogenomics
    Thompson, Miles D.
    Reiner-Link, David
    Berghella, Alessandro
    Rana, Brinda K.
    Rovati, G. Enrico
    Capra, Valerie
    Gorvin, Caroline M.
    Hauser, Alexander S.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (08) : 641 - 684
  • [27] Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING
    Shore, Derek M.
    Baillie, Gemma L.
    Hurst, Dow H.
    Navas, Frank, III
    Seltzman, Herbert H.
    Marcu, Jahan P.
    Abood, Mary E.
    Ross, Ruth A.
    Reggio, Patricia H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) : 5828 - 5845
  • [28] A CLONED-G PROTEIN-COUPLED PROTEIN WITH A DISTRIBUTION RESTRICTED TO STRIATAL MEDIUM-SIZED NEURONS - POSSIBLE RELATIONSHIP WITH D1 DOPAMINE RECEPTOR
    SCHIFFMANN, SN
    LIBERT, F
    VASSART, G
    DUMONT, JE
    VANDERHAEGHEN, JJ
    BRAIN RESEARCH, 1990, 519 (1-2) : 333 - 337
  • [29] Lysolipid Chain Length Switches Agonistic to Antagonistic G Protein-Coupled Receptor Modulation
    Guy, Adam T.
    Ding, Feiqing
    Abe, Junpei
    Inoue, Mariko
    Hirabayashi, Yoshio
    Ito, Yukishige
    Kamiguchi, Hiroyuki
    Greimel, Peter
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (21): : 3635 - 3645
  • [30] G2A is an oncogenic G protein-coupled receptor
    Irene E Zohn
    Mark Klinger
    Xantha Karp
    Heather Kirk
    Marc Symons
    Magdalena Chrzanowska-Wodnicka
    Channing J Der
    Robert J Kay
    Oncogene, 2000, 19 : 3866 - 3877